申请人:American Home Products Corporation
公开号:US05103014A1
公开(公告)日:1992-04-07
There are disclosed compounds of the formula ##STR1## wherein X is ##STR2## Y is ##STR3## Z is --(CH.sub.2).sub.n O--, --(CH.sub.2).sub.n S--, ##STR4## R.sup.1 is ##STR5## n is 0-5; R.sup.2 is hydrogen, loweralkyl, loweralkoxy, lower alkoxycarbonyl, trifluoromethyl, nitro, cyano or halo; R.sup.3 is ##STR6## W represents a bond or --O--, --S-- or ##STR7## m is 1-15; R.sup.4 is hydrogen or loweralkyl; R.sup.5 is lower alkyl, monofluoroloweralkyl, difluroloweralkyl, polyfluroloweralkyl, perfluoroloweralkyl or ##STR8## R.sup.6 is hydrogen lower alkyl, --COOR.sup.4 or ##STR9## R.sup.7 is OR.sup.4 or N(R.sup.4).sub.2 ; R.sup.8 is OR.sup.4 or N(R.sup.4).sub.2 ; and the pharmaceutically acceptable salts thereof, and their use in the treatment of leukotriene-mediated naso-bronchial obstruction airpassageway conditions, such as allergic rhinitis, allergic bronchial asthma and the like, as antiinflammatory agents.
披露了以下式的化合物:其中X是,Y是,Z是--(CH.sub.2).sub.n O--, --(CH.sub.2).sub.n S--, R.sup.1是,n为0-5;R.sup.2是氢、较低烷基、较低烷氧基、较低烷氧羰基、三氟甲基、硝基、氰基或卤素;R.sup.3是;W代表键或--O--, --S--或m为1-15;R.sup.4是氢或较低烷基;R.sup.5是较低烷基、单氟较低烷基、二氟较低烷基、多氟较低烷基、全氟较低烷基或;R.sup.6是氢、较低烷基、--COOR.sup.4或;R.sup.7是OR.sup.4或N(R.sup.4).sub.2;R.sup.8是OR.sup.4或N(R.sup.4).sub.2;以及其药用可接受的盐,以及它们在治疗白三烯介导的鼻支气管阻塞气道疾病条件中的用途,例如过敏性鼻炎、过敏性支气管哮喘等,作为抗炎药。